PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17307376-8	2007	RESULTS: GH treatment decreased hepatic triglyceride content and increased hepatic triglyceride secretion rate and serum cholesterol levels.	Cholesterol	121-132	growth hormone	Mus musculus	9-11	
25152388-8	2014	On the contrary, GH increased levels of glucose, cholesterol and leptin in plasma, and p-mTOR or p-p38 in livers, and decreased plasma adiponectin and hepatic IR beta-subunit compared to saline treatment.	Cholesterol	49-60	growth hormone	Mus musculus	17-19	
11387232-0	2001	Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice.	Cholesterol	30-41	growth hormone	Mus musculus	0-14	
11387232-1	2001	Growth hormone (GH) has pleiotropic effects on cholesterol and lipoprotein metabolism.	Cholesterol	47-58	growth hormone	Mus musculus	0-14	
11387232-1	2001	Growth hormone (GH) has pleiotropic effects on cholesterol and lipoprotein metabolism.	Cholesterol	47-58	growth hormone	Mus musculus	16-18	
11387232-2	2001	Pituitary GH is important for the normal regulation of hepatic LDL receptors (LDLR), for the enzymatic activity of bile acid regulatory cholesterol 7alpha-hydroxylase (C7alphaOH), and for the maintenance of resistance to dietary cholesterol.	Cholesterol	136-147	growth hormone	Mus musculus	10-12	
11387232-5	2001	In LDLR mice, GH infusion reduced plasma cholesterol and triglycerides up to 40%, whereas HMG CoA reductase and C7alphaOH activities were stimulated by approximately 50% and 110% respectively.	Cholesterol	41-52	growth hormone	Mus musculus	14-16	
30130150-0	2018	IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1.	Cholesterol	16-27	growth hormone	Mus musculus	57-71